Letter from Health Organizations: NAFTA Renegotiations Must Not Undermine Access to Affordable Medicines
Letters • 2018A group of 97 International, U.S., Canadian, and Mexican health organizations sent this letter to representatives of those countries, asking them to ensure that any North American Free Trade Agreement (NAFTA) renegotiations don’t undermine access to affordable medicines.
Getting Rid of the Boogeyman: The Reality of Prescription Drug Price Controls
TAGline • 2018By Annette Gaudino, HCV/HIV Project Co-Director, TAG Do you remember how old you were when you stopped believing in the monster under your bed? How many times did you have to look and see nothing there before you finally believed the danger wasn’t real? In the United States, the fear that price controls would irrevocably…
Whose Intellect? Whose Property? A Blueprint for Bringing Down the Pharma IP House of Cards
TAGline • 2018By JD Davids, TAGline Guest Editor and Suraj Madoori, U.S. and Global Health Policy Director, TAG As the Trump administration makes noise about the high price of pharmaceuticals while doubling down on its commitment to “protect the engine of American ingenuity,” this issue of TAGline dives deep into the rhetoric and realities of intellectual property …
TAG Comment on Penalties Relating to the ClinicalTrials.gov Data Bank
Letters • 2018Read TAG's comment on The Food and Drug Administration (FDA) Notice: Civil Money Penalties Relating to the ClinicalTrials.gov Data Bank; Draft Guidance for Food and Drug Administration Staff, Responsible Parties, and Submitters of Certain Applications and Submissions to the FDA.
TAG Welcomes Price Reductions for TB Medicines
Statement / Press • 2018Countries and donors must do more to ensure all people with TB have access; further price reductions for newer medicines required.
TAG Applauds Governor Cuomo’s Commitment to Eliminate Hepatitis C, Expansion of Enhanced Rental Assistance for People Living with HIV in New York State
Statement / Press • 2018Responding to unprecedented advocacy by community leaders, people living with hepatitis C, and communities impacted by the epidemic, Governor Cuomo today announced New York State’s commitment to eliminate hepatitis C as a public health threat. The Governor’s announcement makes New York State the first jurisdiction to declare the intention to eliminate hepatitis C, the deadliest infectious disease in the U.S. Advocates, who had long demanded that New York build on its historic End the Epidemic initiative against HIV/AIDS, applauded this breakthrough in the fight against hepatitis C.
Comment in Response to Proposed Rulemaking: Inadmissibility on Public Charge Grounds
Letters • 2018On October 10, 2018, the Trump Administration proposed sweeping regulations that would put the health and wellbeing of millions of families at risk. TAG is strongly opposed to these proposed changes; read the comment we submitted on December 7.
The TB CAB and TAG Welcome WHO Recommendation of Injectable-Free Regimens for the Treatment of RR/MDR-TB
Statement / Press • 2018The Global Tuberculosis Community Advisory Board (TB CAB) and Treatment Action Group (TAG) welcome the new World Health Organization (WHO) recommendation of injectable-free regimens for the treatment of rifampicin- and multidrug-resistant tuberculosis (RR/MDR-TB).
The United Nations’ Back Yard: TB Elimination in New York State and the U.S.
TAGline • 2018By Erica Lessem The road from Moscow has led us back to New York, home of the United Nations (UN) and TAG headquarters. New York is also home to one of the largest tuberculosis (TB) burdens in the U.S.[1] Incidence in New York City rose in 2017, and multidrug-resistant TB (MDR-TB), which is costly and…
It’s up to You, New York: Moving towards HCV Elimination in the Empire State
TAGline • 2018By Annette Gaudino Governor Andrew Cuomo’s March 16 announcement committing New York State (NYS) to ending the hepatitis C virus (HCV) epidemic was the culmination of years of advocacy on a path that paralleled—and is built upon—the state’s nation leading efforts to end the HIV epidemic. The HCV burden in NYS, and in the U.S.,…